JP2018529671A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018529671A5 JP2018529671A5 JP2018511491A JP2018511491A JP2018529671A5 JP 2018529671 A5 JP2018529671 A5 JP 2018529671A5 JP 2018511491 A JP2018511491 A JP 2018511491A JP 2018511491 A JP2018511491 A JP 2018511491A JP 2018529671 A5 JP2018529671 A5 JP 2018529671A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- pharmaceutically acceptable
- phosphoryl
- dioxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 26
- -1 (phenoxy) phosphoryl Chemical group 0.000 claims 13
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 7
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 241000711549 Hepacivirus C Species 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims 2
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 claims 2
- KJDMHQIHCXUXAM-PHHLIPDPSA-N ethyl 2-[[[(2R,3R,4R,5R)-4-bromo-4-chloro-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]-2-methylpropanoate Chemical compound Br[C@@]1([C@@H]([C@H](O[C@H]1N1C(NC(C=C1)=O)=O)CO[P@](=O)(OC1=CC=CC=C1)NC(C(=O)OCC)(C)C)O)Cl KJDMHQIHCXUXAM-PHHLIPDPSA-N 0.000 claims 1
- KJDMHQIHCXUXAM-YTBGVTTRSA-N ethyl 2-[[[(2R,3R,4R,5R)-4-bromo-4-chloro-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]-2-methylpropanoate Chemical compound Br[C@@]1([C@@H]([C@H](O[C@H]1N1C(NC(C=C1)=O)=O)CO[P@@](=O)(OC1=CC=CC=C1)NC(C(=O)OCC)(C)C)O)Cl KJDMHQIHCXUXAM-YTBGVTTRSA-N 0.000 claims 1
- IVBQJSWAIJZGDV-IHCGESCNSA-N ethyl 2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]-2-methylpropanoate Chemical compound O=C1N(C=CC(N1)=O)[C@H]1[C@]([C@@H]([C@H](O1)COP(=O)(OC1=CC=CC=C1)NC(C(=O)OCC)(C)C)O)(C)F IVBQJSWAIJZGDV-IHCGESCNSA-N 0.000 claims 1
- OEFWWTWBGKIMOJ-KXINHHJESA-N ethyl 2-[[[(2R,3R,4S,5R)-4-bromo-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]-2-methylpropanoate Chemical compound Br[C@]1([C@@H]([C@H](O[C@H]1N1C(NC(C=C1)=O)=O)CO[P@@](=O)(OC1=CC=CC=C1)NC(C(=O)OCC)(C)C)O)F OEFWWTWBGKIMOJ-KXINHHJESA-N 0.000 claims 1
- OEFWWTWBGKIMOJ-LVGFUXGXSA-N ethyl 2-[[[(2R,3R,4S,5R)-4-bromo-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]-2-methylpropanoate Chemical compound Br[C@]1([C@@H]([C@H](O[C@H]1N1C(NC(C=C1)=O)=O)CO[P@](=O)(OC1=CC=CC=C1)NC(C(=O)OCC)(C)C)O)F OEFWWTWBGKIMOJ-LVGFUXGXSA-N 0.000 claims 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 1
- 0 C[C@@](C(*[C@]1(*)COP)N(C=CC(N2)=O)C2=O)[C@@]1(*)*(C)=* Chemical compound C[C@@](C(*[C@]1(*)COP)N(C=CC(N2)=O)C2=O)[C@@]1(*)*(C)=* 0.000 description 2
- GFADCAXVBCLJGH-YUNKPMOVSA-N CC(C)C(OC[C@H](C)N[P@](C)(Oc1ccccc1)=O)=O Chemical compound CC(C)C(OC[C@H](C)N[P@](C)(Oc1ccccc1)=O)=O GFADCAXVBCLJGH-YUNKPMOVSA-N 0.000 description 1
- CDWPKRNDHQACEI-JRTLGTJJSA-N CCP(N[C@@H](C)C(OC(C)C)=O)(Oc1cccc(C)c1)=O Chemical compound CCP(N[C@@H](C)C(OC(C)C)=O)(Oc1cccc(C)c1)=O CDWPKRNDHQACEI-JRTLGTJJSA-N 0.000 description 1
Applications Claiming Priority (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562213378P | 2015-09-02 | 2015-09-02 | |
| US62/213,378 | 2015-09-02 | ||
| US201562242136P | 2015-10-15 | 2015-10-15 | |
| US62/242,136 | 2015-10-15 | ||
| US201562253426P | 2015-11-10 | 2015-11-10 | |
| US62/253,426 | 2015-11-10 | ||
| US201662294449P | 2016-02-12 | 2016-02-12 | |
| US62/294,449 | 2016-02-12 | ||
| US201662296801P | 2016-02-18 | 2016-02-18 | |
| US62/296,801 | 2016-02-18 | ||
| US201662321538P | 2016-04-12 | 2016-04-12 | |
| US62/321,538 | 2016-04-12 | ||
| US201662327087P | 2016-04-25 | 2016-04-25 | |
| US62/327,087 | 2016-04-25 | ||
| US201662351038P | 2016-06-16 | 2016-06-16 | |
| US62/351,038 | 2016-06-16 | ||
| US201662363640P | 2016-07-18 | 2016-07-18 | |
| US62/363,640 | 2016-07-18 | ||
| US201662375029P | 2016-08-15 | 2016-08-15 | |
| US62/375,029 | 2016-08-15 | ||
| PCT/US2016/049873 WO2017040766A1 (en) | 2015-09-02 | 2016-09-01 | Anti-viral tetrahydrofurane derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018529671A JP2018529671A (ja) | 2018-10-11 |
| JP2018529671A5 true JP2018529671A5 (enExample) | 2019-11-21 |
| JP6743135B2 JP6743135B2 (ja) | 2020-08-19 |
Family
ID=56926317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511491A Expired - Fee Related JP6743135B2 (ja) | 2015-09-02 | 2016-09-01 | 抗ウィルス性テトラヒドロフラン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9676797B2 (enExample) |
| EP (1) | EP3344642A1 (enExample) |
| JP (1) | JP6743135B2 (enExample) |
| CN (1) | CN108350016B (enExample) |
| CA (1) | CA2997170A1 (enExample) |
| MX (1) | MX2018002707A (enExample) |
| WO (1) | WO2017040766A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016178876A2 (en) * | 2015-05-01 | 2016-11-10 | Cocrystal Pharma, Inc. | Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer |
| EP3344642A1 (en) * | 2015-09-02 | 2018-07-11 | AbbVie Inc. | Anti-viral tetrahydrofurane derivatives |
| WO2018093717A1 (en) * | 2016-11-17 | 2018-05-24 | Abbvie Inc. | Compositions and methods for treating hcv infection |
| US10435429B2 (en) | 2017-10-03 | 2019-10-08 | Nucorion Pharmaceuticals, Inc. | 5-fluorouridine monophosphate cyclic triester compounds |
| EP3752511A4 (en) | 2018-01-10 | 2021-12-29 | Nucorion Pharmaceuticals, Inc. | Phosphor(n)amidatacetal and phosph(on)atalcetal compounds |
| US11427550B2 (en) | 2018-01-19 | 2022-08-30 | Nucorion Pharmaceuticals, Inc. | 5-fluorouracil compounds |
| CN109762040A (zh) * | 2019-01-14 | 2019-05-17 | 歌礼生物制药(杭州)有限公司 | 一种核苷类ns5b聚合酶抑制剂的制备方法 |
| EP3999519A4 (en) | 2019-07-17 | 2023-08-16 | Nucorion Pharmaceuticals, Inc. | CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS |
| WO2021216427A1 (en) | 2020-04-21 | 2021-10-28 | Ligand Pharmaceuticals, Inc. | Nucleotide prodrug compounds |
| US12274700B1 (en) | 2020-10-30 | 2025-04-15 | Accencio LLC | Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526988A (en) | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
| US5246924A (en) | 1987-09-03 | 1993-09-21 | Sloan-Kettering Institute For Cancer Research | Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil |
| SE8802687D0 (sv) | 1988-07-20 | 1988-07-20 | Astra Ab | Nucleoside derivatives |
| US6060592A (en) | 1990-01-11 | 2000-05-09 | Isis Pharmaceuticals, Inc. | Pyrimidine nucleoside compounds and oligonucleoside compounds containing same |
| US6060542A (en) | 1997-05-16 | 2000-05-09 | Shell Oil Company | Bitumen compositions and a process for their preparation |
| US6348587B1 (en) | 1998-02-25 | 2002-02-19 | Emory University | 2′-Fluoronucleosides |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| AU2001272923A1 (en) | 2000-05-26 | 2001-12-11 | Idenix (Cayman) Limited | Methods and compositions for treating flaviviruses and pestiviruses |
| JP2004513070A (ja) | 2000-05-26 | 2004-04-30 | イデニクス(ケイマン)リミテツド | β−L−2’−デオキシヌクレオシドを用いたデルタ型肝炎ウイルス感染の処置方法 |
| US6787526B1 (en) | 2000-05-26 | 2004-09-07 | Idenix Pharmaceuticals, Inc. | Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
| US20030008841A1 (en) | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| WO2002028862A2 (en) * | 2000-10-02 | 2002-04-11 | Emory University | Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| EP1411954B1 (en) | 2000-10-18 | 2010-12-15 | Pharmasset, Inc. | Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| US7105499B2 (en) | 2001-01-22 | 2006-09-12 | Merck & Co., Inc. | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| US8481712B2 (en) | 2001-01-22 | 2013-07-09 | Merck Sharp & Dohme Corp. | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| JP2004532184A (ja) | 2001-01-22 | 2004-10-21 | メルク エンド カムパニー インコーポレーテッド | Rna依存性rnaウィルスポリメラーゼ阻害薬としてのヌクレオシド誘導体 |
| EP1435974A4 (en) | 2001-09-28 | 2006-09-06 | Idenix Cayman Ltd | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS C VIRUS USING 4 'MODIFIED NUCLEOSIDES |
| CA2488842A1 (en) | 2002-06-17 | 2003-12-24 | Merck & Co., Inc. | Carbocyclic nucleoside analogs as rna-antivirals |
| AU2003269890A1 (en) | 2002-06-21 | 2004-01-06 | Isis Pharmaceuticals, Inc. | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| KR20050035194A (ko) | 2002-06-28 | 2005-04-15 | 이데닉스 (케이만) 리미티드 | 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘 |
| CN1849142A (zh) | 2002-11-15 | 2006-10-18 | 埃迪尼克斯(开曼)有限公司 | 2′-支链核苷和黄病毒突变 |
| KR20050109918A (ko) | 2002-12-12 | 2005-11-22 | 이데닉스 (케이만) 리미티드 | 2'-분지형 뉴클레오시드의 제조 방법 |
| EP1745573A4 (en) * | 2003-03-20 | 2010-05-26 | Microbiol Quimica Farmaceutica | PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES |
| KR100883703B1 (ko) | 2003-05-30 | 2009-02-12 | 파마셋 인코포레이티드 | 변형 불소화 뉴클레오시드 유사체 |
| GB0317009D0 (en) | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
| EP1827460A4 (en) | 2004-12-09 | 2012-03-14 | Univ Minnesota | NUCLEOSIDE WITH ANTIVIRAL AND ANTI-CANCER EFFECT |
| US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
| WO2006121820A1 (en) | 2005-05-05 | 2006-11-16 | Valeant Research & Development | Phosphoramidate prodrugs for treatment of viral infection |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| PA8852101A1 (es) | 2008-12-08 | 2010-07-27 | Medivir Ab | Nucleótidos uracil ciclopropílicos |
| TWI583692B (zh) | 2009-05-20 | 2017-05-21 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| PL2368890T3 (pl) | 2009-06-11 | 2013-10-31 | Abbvie Bahamas Ltd | Inhibitory wirusa zapalenia wątroby C |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| US9790252B2 (en) | 2009-07-01 | 2017-10-17 | Cornell University | 2-fluorinated riboses and arabinoses and methods of use and synthesis |
| EP2464647B1 (en) * | 2009-08-11 | 2016-09-21 | Bristol-Myers Squibb Company | Azaindazoles as btk kinase modulators and use thereof |
| US9700560B2 (en) | 2009-11-16 | 2017-07-11 | University Of Georgia Research Foundation, Inc. | 2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections |
| EA026341B9 (ru) * | 2010-03-31 | 2021-12-27 | ГАЙЛИД ФАРМАССЕТ ЭлЭлСи | Кристаллическая форма нуклеозидфосфорамидата |
| WO2012040126A1 (en) * | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| US8841275B2 (en) | 2010-11-30 | 2014-09-23 | Gilead Pharmasset Llc | 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections |
| US9156874B2 (en) * | 2011-01-03 | 2015-10-13 | Nanjing Molecular Research, Inc. | Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs |
| CA2843324A1 (en) | 2011-03-31 | 2012-11-15 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of viral infections |
| EA201391519A1 (ru) | 2011-04-13 | 2014-03-31 | Мерк Шарп И Доум Корп. | 2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний |
| EP2697241B1 (en) * | 2011-04-13 | 2019-06-12 | Gilead Sciences, Inc. | 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| US20130143835A1 (en) * | 2011-12-05 | 2013-06-06 | Medivir Ab | HCV Polymerase Inhibitors |
| PL2794629T3 (pl) * | 2011-12-20 | 2018-02-28 | Riboscience Llc | 2',4'-difluoro-2'-metylo-podstawione pochodne nukleozydowe jako inhibitory replikacji rna hcv |
| PT2794628T (pt) * | 2011-12-20 | 2017-07-05 | Riboscience Llc | Derivados nucleosídicos 4¿-azido-3¿-fluoro substituídos como inibidores de replicação de arn de vhc |
| CN104640444B (zh) * | 2012-06-16 | 2016-12-14 | 河南美泰宝生物制药有限公司 | 双肝脏靶向氨基磷酸酯和氨基膦酸酯前药 |
| CN102751200B (zh) | 2012-06-29 | 2015-06-10 | 京东方科技集团股份有限公司 | 薄膜晶体管、阵列基板及其制造方法 |
| US20140065101A1 (en) * | 2012-08-31 | 2014-03-06 | Novartis Ag | 2'-Branched Nucleosides for Treatment of Viral Infections |
| HK1207647A1 (en) | 2012-10-08 | 2016-02-05 | Idenix Pharmaceuticals Llc | 2'-chloro nucleoside analogs for hcv infection |
| AR092959A1 (es) | 2012-10-17 | 2015-05-06 | Merck Sharp & Dohme | Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
| EP2935304A1 (en) | 2012-12-19 | 2015-10-28 | IDENIX Pharmaceuticals, Inc. | 4'-fluoro nucleosides for the treatment of hcv |
| ES2865402T3 (es) | 2012-12-21 | 2021-10-15 | Janssen Biopharma Inc | 4'-fluoronucleósidos, 4'-fluoronucleótidos y análogos de los mismos para el tratamiento del VHC |
| US10034893B2 (en) | 2013-02-01 | 2018-07-31 | Enanta Pharmaceuticals, Inc. | 5, 6-D2 uridine nucleoside/tide derivatives |
| CA2909270A1 (en) | 2013-04-12 | 2014-10-16 | Achillion Pharmaceuticals, Inc. | Highly active nucleoside derivative for the treatment of hcv |
| EP3013340B9 (en) | 2013-06-26 | 2023-10-04 | Janssen Pharmaceuticals, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| UA117375C2 (uk) | 2013-09-04 | 2018-07-25 | Медівір Аб | Інгібітори полімерази hcv |
| WO2015038596A1 (en) | 2013-09-11 | 2015-03-19 | Emory University | Nucleotide and nucleoside compositions and uses related thereto |
| JP6562908B2 (ja) | 2013-10-11 | 2019-08-21 | ヤンセン バイオファーマ インク. | 置換ヌクレオシド、置換ヌクレオチドおよびその類似体 |
| EP3057976A1 (en) * | 2013-10-17 | 2016-08-24 | Medivir Ab | Hcv polymerase inhibitors |
| WO2015077360A2 (en) * | 2013-11-20 | 2015-05-28 | Idenix Pharmaceuticals, Inc. | Cyclopentane and cyclopentene nucleoside analogs for the treatment of hcv |
| EP3074399A1 (en) | 2013-11-27 | 2016-10-05 | Idenix Pharmaceuticals LLC | 2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection |
| WO2015120014A1 (en) * | 2014-02-05 | 2015-08-13 | Merck Sharp & Dohme Corp. | Novel disintegration systems for pharmaceutical dosage forms |
| WO2015161137A1 (en) | 2014-04-16 | 2015-10-22 | Idenix Pharmaceuticals, Inc. | 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv |
| EP3134423A4 (en) | 2014-04-24 | 2017-11-29 | Cocrystal Pharma, Inc. | 2' -disubstituted nucleoside analogs for treatment of the flaviviridae family of viruses and cancer |
| US20170334941A1 (en) | 2014-10-31 | 2017-11-23 | Cocrystal Pharma, Inc. | 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer |
| WO2016178876A2 (en) | 2015-05-01 | 2016-11-10 | Cocrystal Pharma, Inc. | Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer |
| EP3344642A1 (en) * | 2015-09-02 | 2018-07-11 | AbbVie Inc. | Anti-viral tetrahydrofurane derivatives |
-
2016
- 2016-09-01 EP EP16766172.7A patent/EP3344642A1/en not_active Withdrawn
- 2016-09-01 CN CN201680063114.8A patent/CN108350016B/zh not_active Expired - Fee Related
- 2016-09-01 JP JP2018511491A patent/JP6743135B2/ja not_active Expired - Fee Related
- 2016-09-01 US US15/254,342 patent/US9676797B2/en active Active
- 2016-09-01 CA CA2997170A patent/CA2997170A1/en not_active Abandoned
- 2016-09-01 MX MX2018002707A patent/MX2018002707A/es unknown
- 2016-09-01 WO PCT/US2016/049873 patent/WO2017040766A1/en not_active Ceased
-
2017
- 2017-05-05 US US15/588,037 patent/US10053474B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018529671A5 (enExample) | ||
| RU2016138735A (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| EA022127B1 (ru) | Ингибиторы вируса гепатита с | |
| JP2020183410A5 (enExample) | ||
| JP2020504733A5 (enExample) | ||
| RU2016122908A (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| JP2010525056A5 (enExample) | ||
| HRP20151075T1 (hr) | Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino) propanoat | |
| JP2024156774A5 (enExample) | ||
| JP2009535352A5 (enExample) | ||
| JP2016538313A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2017523225A5 (enExample) | ||
| JP2015514806A5 (enExample) | ||
| JP2014513110A5 (enExample) | ||
| JP2015529652A5 (enExample) | ||
| JP2017526677A5 (enExample) | ||
| JP2012519691A5 (enExample) | ||
| JP2021500394A5 (enExample) | ||
| JP2010500414A5 (enExample) | ||
| JP2010504346A5 (enExample) | ||
| JP2012528161A5 (enExample) | ||
| RU2013112744A (ru) | Алкил 2-{[(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)-гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино}-пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения | |
| JP2017531619A5 (enExample) | ||
| JP2013514980A5 (enExample) |